News

Venturing Into New Treatment Territory for Myelofibrosis with a Fox Chase Investigator-Initiated Study

The study is a phase one, single-site, dose-escalation study for patients with myeloproliferative neoplasms unresponsive to any JAK2 inhibitor. It combines two oral medications, Pacritinib and Talazoparib, and is for transplant-ineligible patients.

News

Fox Chase Cancer Center’s Dr. Thomas J. Galloway Named a Fellow of the American Society for Radiation Oncology

Thomas J. Galloway, MD, Chief of the Division of Head and Neck Radiation Oncology at Fox Chase Cancer Center, was today named a Fellow of the American Society for Radiation Oncology (ASTRO) at its 66th Annual Meeting in Washington, D.C.

Document

Thoracic Malignancies: A Review of the Latest Evidence - AGENDA

Presented by Fox Chase Cancer Center, the Temple Lung Center, and the Temple Health Office for Continuing Medical Education

News

Fox Chase Cancer Center Researchers Show Adaptive Radiation Therapy Effectively Delivers Treatment For Liver Tumors in Study Presented at American Society For Radiation Oncology Meeting

Using CT-guided online adaptive radiation therapy (ART) for patients with liver tumors has proven to be an effective approach, according to findings presented today by Fox Chase Cancer Center researchers at the American Society for Radiation ...

News

Fox Chase Cancer Center and Lewis Katz School of Medicine at Temple University’s Dr. Eric Horwitz Elected to Executive Committee of Radiation Oncology Society

Eric Horwitz, MD, FABS, FASTRO, Chair of the Department of Radiation Oncology at Fox Chase Cancer Center and the Lewis Katz School of Medicine at Temple University, was elected to the Executive Committee of the Society of Chairs of Academic ...

News

Fox Chase Cancer Center Researchers Show Adaptive Radiation Therapy Delivers Treatment More Effectively in Study Presented at American Society for Radiation Oncology Meeting

Online adaptive radiation therapy (ART) delivered radiation more effectively than conventional radiation therapy in nearly half of patients, while also helping to decrease radiation dose to the esophagus in a majority of patients with ...

News

GASTROINTESTINAL CANCER PROGRAM

Comprehensive Care That Empowers Patients Through Risk Management, Prevention, Detection, Treatment, and Survivorship Services

News

MELANOMA AND SKIN CANCER PROGRAM

Comprehensive Care Empowers Patients Through Risk Assessment, Prevention, Detection, Treatment, and Survivorship

News

BREAST CANCER PROGRAM

Comprehensive Care That Empowers Patients Through Risk Management, Prevention, Detection, Treatment, and Survivorship Services